Literature DB >> 14526445

Effect of catecholamine on central serous chorioretinopathy.

Jinghua Sun1, Junfeng Tan, Zhitao Wang, Hong Yang, Xuefei Zhu, Lingli Li.   

Abstract

The role of catecholamine (CA) in the pathogenesis and development of macular edema of central serous chorioretinopathy (CSC) was studied, and its relations with visual acuity were investigated. Plasma concentrations of epinephrine (E) and norepinephrine (NE) were determined in 30 consecutive eyes with CSC. Central macular thickness analysis was done by RTA and all the data were compared with normal eyes and analyzed with SAS software package. Plasma concentrations of E and NE were increased to (569 +/- 123) ng/L and (721 +/- 104) ng/L respectively in active CSC patients, significantly higher than those in normal subjects (P < 0.01), and decreased to normal in convalescent stage. RTA analysis revealed that the retinal thickness of CSC patients was increased at active and recovery stage as compared with normal subjects; and the plasma concentration of E was significantly correlated with central macular thickness (t = 2.173, P < 0.05). Also, central macular thickness measured by RTA was significantly correlated with the visual acuity (r = -0.8046, P < 0.001) in CSC eyes. RTA analysis might be useful to quantitatively detect and evaluate prognosis in CSC patients. The plasma concentration of E, which was highly correlated with macular edema, might play an important role in the early damage and the pathogenesis of CSC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14526445     DOI: 10.1007/bf02829525

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  7 in total

1.  Quantitative assessment of macular thickness in normal subjects and patients with diabetic retinopathy by scanning retinal thickness analyser.

Authors:  Y Oshima; K Emi; S Yamanishi; M Motokura
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

2.  A new method for rapid mapping of the retinal thickness at the posterior pole.

Authors:  R Zeimer; M Shahidi; M Mori; S Zou; S Asrani
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-09       Impact factor: 4.799

3.  Pathogenesis of disciform detachment of the neuroepithelium.

Authors:  J D Gass
Journal:  Am J Ophthalmol       Date:  1967-03       Impact factor: 5.258

Review 4.  Type-A behavior and central serous chorioretinopathy.

Authors:  L A Yannuzzi
Journal:  Retina       Date:  1987       Impact factor: 4.256

5.  Use of alumina, sephadex G10, and ion-exchange columns to purify samples for determination of epinephrine, norepinephrine, dopamine, homovanillic acid, and 5-hydroxyindoleacetic acid in urine.

Authors:  B H Westerink; F J Bosker; J F O'Hanlon
Journal:  Clin Chem       Date:  1982-08       Impact factor: 8.327

6.  Choroidal capillary and venous congestion in central serous chorioretinopathy.

Authors:  C Prünte; J Flammer
Journal:  Am J Ophthalmol       Date:  1996-01       Impact factor: 5.258

7.  Experimental central serous chorioretinopathy in monkey eyes: fluorescein angiographic findings.

Authors:  H Yoshioka; Y Katsume; H Akune
Journal:  Ophthalmologica       Date:  1982       Impact factor: 3.250

  7 in total
  12 in total

1.  [Central serous chorioretinopathy (CSC)].

Authors:  H Baraki; N Feltgen; J Roider; H Hoerauf; C Klatt
Journal:  Ophthalmologe       Date:  2010-05       Impact factor: 1.059

Review 2.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

3.  Obstructive sleep apnea in patients with central serous chorioretinopathy.

Authors:  Patrik Kloos; Irene Laube; Adelheid Thoelen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-06-11       Impact factor: 3.117

4.  Relationship between mean platelet volume and central serous chorioretinopathy.

Authors:  Ayhan Dursun; Mustafa Ilker Toker; Ayşe Vural Ozec; Erman Bozali; Kadir Kirboga; Feyza Gulac Dursun; Haydar Erdogan; Aysen Topalkara; Mustafa Kemal Arici
Journal:  Int Ophthalmol       Date:  2016-04-25       Impact factor: 2.031

5.  Massive Retinal Pigment Epithelial Detachment Following Acute Hypokalemic Quadriparesis in Dengue Fever.

Authors:  Neha Goel; Vishaal Bhambhwani; Pooja Jain; Basudeb Ghosh
Journal:  J Ophthalmic Vis Res       Date:  2016 Apr-Jun

6.  Choroidal and Retinal Abnormalities by Optical Coherence Tomography in Endogenous Cushing's Syndrome.

Authors:  Maria Fernanda Abalem; Marcio Carlos Machado; Helen Nazareth Veloso Dos Santos; Rafael Garcia; John Helal; Pedro Carlos Carricondo; Sérgio Luis Gianotti Pimentel; Mario Luiz Ribeiro Monteiro; Cynthia X Qian; Marcello Delano Bronstein; Maria Cândida Villares Barisson Fragoso
Journal:  Front Endocrinol (Lausanne)       Date:  2016-12-09       Impact factor: 5.555

7.  Increased Risk of Central Serous Chorioretinopathy among Patients with Nonorganic Sleep Disturbance.

Authors:  Peng-Tai Tien; Chien-Yu Lai; Chun-Ju Lin; Wen-Lu Chen; Po-Kang Lin; Chih-Hsin Muo; Yi-Yu Tsai; Lei Wan; Wen-Chao Ho; Hui-Ju Lin
Journal:  J Ophthalmol       Date:  2020-02-12       Impact factor: 1.909

8.  Personality Traits, Stress, and Emotional Intelligence Associated with Central Serous Chorioretinopathy.

Authors:  Anita Pusic Sesar; Antonio Sesar; Kajo Bucan; Irena Sesar; Katarina Cvitkovic; Ivan Cavar
Journal:  Med Sci Monit       Date:  2021-01-10

9.  Relationship of Choroidal Vasculature and Choriocapillaris Flow With Alterations of Salivary α-Amylase Patterns in Central Serous Chorioretinopathy.

Authors:  Fabio Scarinci; Francesca Romana Patacchioli; Eliana Costanzo; Mariacristina Parravano
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-12-01       Impact factor: 4.925

Review 10.  Central serous chorioretinopathy: Current update on pathophysiology and multimodal imaging.

Authors:  George Joseph Manayath; Ratnesh Ranjan; Vanee Sheth Shah; Smita S Karandikar; Veerappan R Saravanan; Venkatapathy Narendran
Journal:  Oman J Ophthalmol       Date:  2018 May-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.